ADR Ontology |
ADR Term |
Hepatic function abnormal |
ADR ID |
BADD_A02005 |
ADR Hierarchy |
|
Description |
Not Available |
MedDRA Code |
10019670 |
MeSH ID |
Not Available
|
ADR Severity Grade (FAERS)
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
Synonym |
Acute derangement of liver function | Dysfunction hepatic nonicteric | Function liver abnormal | Function liver decreased | Hepatic dysfunction allergic | Hepatic dysfunction nonicteric | Hepatic dysfunction NOS | Hepatic dysfunction transient | Hepatic function abnormal | Hepatic function abnormal NOS | Hepatic function aggravated | Hepatic function decreased | Hepatic function disorder | Impaired liver function | Hepatic function abnormal aggr. | Hepatic dysfunction non-icteric | Dysfunction hepatic non-icteric |
|
|
ADR Related Proteins |
Protein Name |
UniProt AC |
TTD Target ID |
Albumin-8 | P23110 | Not Available | Cyclin-A1 | Q61456 | Not Available | Cyclin-F | P51944 | Not Available | Epidermal growth factor receptor | P00533 | T59328 | G1/S-specific cyclin-D1 | P25322 | Not Available | G2/mitotic-specific cyclin-B1 | P24860 | Not Available | G2/mitotic-specific cyclin-B2 | P30276 | Not Available | Glycogen [starch] synthase, muscle | P13807 | Not Available | Haptoglobin | P00738 | T17710 | Hepatocyte growth factor | P14210 | T83797 |
|
Drugs Leading to the ADR |
|